Laura A. Bruins
- Hematology top 1%
- Multiple Myeloma Research and Treatments 26
- Molecular Biology top 10%
- Protein Degradation and Inhibitors 23
- Ubiquitin and proteasome pathways 10
- Histone Deacetylase Inhibitors Research 4
- Cancer therapeutics and mechanisms 2
- Oncology top 10%
- Peptidase Inhibition and Analysis 7
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 2
-
- Cancer Mechanisms and Therapy 2
- Co-authors
- Esteban BraggioA. Keith StewartChang-Xin ShiYuan Xiao ZhuP. Leif BergsagelJessica SchmidtRafaël FonsecaXiu-Bao Chang
- Cited by
- HematologyMolecular BiologyOncology
- Partner nations
- United StatesGermanyIndia
In The Last Decade
Laura A. Bruins
30 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 60
- Hematology 969
- Molecular Biology 1.1k
- Oncology 437
- Genetics 90
- Pathology and Forensic Medicine 112
Countries citing papers authored by Laura A. Bruins
This map shows the geographic impact of Laura A. Bruins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura A. Bruins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura A. Bruins more than expected).
Fields of papers citing papers by Laura A. Bruins
This network shows the impact of papers produced by Laura A. Bruins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura A. Bruins. The network helps show where Laura A. Bruins may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Laura A. Bruins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2020 | 23 | |
| 3 | 2019 | 70 | |
| 4 | 2019 | 24 | |
| 5 | 2017 | 42 | |
| 6 | 2017 | 53 | |
| 7 | 2016 | 32 | |
| 8 | 2016 | 177 | |
| 9 | 2015 | 36 | |
| 10 | 2015 | 1 | |
| 11 | 2015 | 1 | |
| 12 | 2015 | 2 | |
| 13 | 2014 | 0 | |
| 14 | 2014 | 18 | |
| 15 | 2013 | 85 | |
| 16 | 2012 | 12 | |
| 17 | 2011 | 81 | |
| 18 | 2011 | 14 | |
| 19 | Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomidebreakdown → | 2011 | 461 |
| 20 | 2005 | 59 |
About Laura A. Bruins
Laura A. Bruins is a scholar working on Hematology, Molecular Biology and Oncology, having authored 31 papers that have together received 1.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (26 papers), Protein Degradation and Inhibitors (23 papers), Ubiquitin and proteasome pathways (10 papers), Peptidase Inhibition and Analysis (7 papers), Histone Deacetylase Inhibitors Research (4 papers), Cancer Mechanisms and Therapy (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Hematology (969 citations), Molecular Biology (1.1k citations) and Oncology (437 citations). Laura A. Bruins has collaborated with scholars based in United States, Germany and India. Frequent co-authors include Esteban Braggio, A. Keith Stewart, Chang-Xin Shi, Yuan Xiao Zhu, P. Leif Bergsagel, Jessica Schmidt, Rafaël Fonseca, Xiu-Bao Chang, Chad C. Bjorklund and Robert Z. Orlowski. Their work appears in journals such as Blood, Blood Cancer Journal, Molecular Cancer Research, Molecular Cancer Therapeutics and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.